UroGen Pharma Ltd. revenue breakdown overview

UroGen Pharma Ltd. revenue for the last year amounted to 82.71 M USD, the most of which — 82.71 M USD — came from its highest performing source at the moment, RTGel Reverse-Thermal Hydrogel, the year earlier bringing 64.36 M USD. The greatest contribution to the revenue figure was made by Israel — last year it brought UroGen Pharma Ltd. 82.71 M USD, and the year before that — 64.36 M USD.